Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of Neoadjuvant Vibecortamab Combined With Putilimab in Locally Advanced Laryngeal Cancer - A Single-Arm, Phase II Study

NCT07538206 is registered in ClinicalTrials.gov with Tang-Du Hospital as lead sponsor.

NCT NCT07538206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07538206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of Neoadjuvant Vibecortamab Combined With Putilimab in Locally Advanced Laryngeal Cancer - A Single-Arm, Phase II Study
Lead sponsor
Tang-Du Hospital
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
April 23, 2026
Completion date
April 23, 2031
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

head & neck cancer